KRAS and colorectal carcinoma: KRAS mutant CRC patients also had higher MPRS scores (P<0.05) and elevated stress granule activity by ssGSEA (P<0.05) (Supplementary Figure S5B), indicating KRAS may driven MLO and SG dysregulation.